Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04BFI
|
|||
| Former ID |
DCL000866
|
|||
| Drug Name |
LGD-4665
|
|||
| Indication | Immune thrombocytopenic purpura [ICD-11: 3B64.13; ICD-10: D69; ICD-9: 287.31] | Phase 2 | [1] | |
| Company |
Ligand
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Thrombopoietin receptor (MPL) | Target Info | Agonist | [1] |
| KEGG Pathway | Cytokine-cytokine receptor interaction | |||
| Jak-STAT signaling pathway | ||||
| WikiPathways | Platelet Aggregation (Plug Formation) | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Emerging drugs for idiopathic thrombocytopenic purpura in adults. Expert Opin Emerg Drugs. 2008 Jun;13(2):237-54. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.